Found: 7
Select item for more details and to access through your institution.
M6A-Related Bioinformatics Analysis Reveals a New Prognostic Risk Signature in Cutaneous Malignant Melanoma.
- Published in:
- Disease Markers, 2022, p. 1, doi. 10.1155/2022/8114731
- By:
- Publication type:
- Article
Knockdown of NCOR2 Inhibits Cell Proliferation via BDNF/TrkB/ERK in NF1-Derived MPNSTs.
- Published in:
- Cancers, 2022, v. 14, n. 23, p. 5798, doi. 10.3390/cancers14235798
- By:
- Publication type:
- Article
Spatiotemporal expression of NRAS and occurrence of giant congenital melanocytic nevi.
- Published in:
- Experimental Dermatology, 2022, v. 31, n. 4, p. 582, doi. 10.1111/exd.14527
- By:
- Publication type:
- Article
Ganoderma spore lipid ameliorates docetaxel, cisplatin, and 5-fluorouracil chemotherapy-induced damage to bone marrow mesenchymal stem cells and hematopoiesis.
- Published in:
- BMC Complementary Medicine & Therapies, 2024, v. 24, n. 1, p. 1, doi. 10.1186/s12906-024-04445-x
- By:
- Publication type:
- Article
Concurrent inhibition of FAK/SRC and MEK overcomes MEK inhibitor resistance in Neurofibromatosis Type I related malignant peripheral nerve sheath tumors.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.910505
- By:
- Publication type:
- Article
Preclinical Assessment of MEK Inhibitors for Malignant Peripheral Nerve Sheath Tumors Reveals Differences in Efficacy and Adaptive Response.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.903177
- By:
- Publication type:
- Article
Image-Based Differentiation of Benign and Malignant Peripheral Nerve Sheath Tumors in Neurofibromatosis Type 1.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.898971
- By:
- Publication type:
- Article